Centro Medico Nacional La Raza, IMSS Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2017
NCT03877120
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Centro Medico Nacional La Raza, IMSS | Hematology Department La Raza Medical Center | La Raza Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Withdrawal Delirium (Phase 4)

Delirium (Phase 4)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Substance Withdrawal Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 7